Asia Breast Cancer Screening Market to reach USD 16.5 Billion by 2027

ROSWELL, Ga. - Nov. 26, 2022 - PRLog -- According to Renub Research latest report titled "Asia Breast Cancer Screening Market, Size, Forecast 2022-2027, Share, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis," Asia Breast Cancer Screening Market, Size will grow to US$ 16.5 Billion by 2027. Asia-Pacific, breast cancer is the most common type of cancer, specifically among females. As per Novotech, the Asia-Pacific CRO, breast cancer impacts 2.1 million patients every year. It is seen in advanced stages and among younger age group women in Asia.

Breast cancer can affect different breast parts like lobes and ducts. Thus, breast cancer screening is done to detect cancer earlier and secure that patients receive immediate treatment. Routine breast screening is necessary to prevent malignancy. Breast cancer screening is a regular test to detect breast cancer. Early detection could provide patients with timely treatment, decreasing the mortality rate. Breast cancer screening commonly involves mammography, scan, MRIs, or ultrasound. Mammography is considered a multiple helpful screening tests for the detection of breast cancer.

Besides, China, Japan, India, Singapore, Thailand, and Korea are the top contributors. Raising breast cancer awareness, government and NGOs funding breast cancer screening programs, and the aging female population is significant driving forces for the Asia breast cancer screening market. In addition, technological advancement is an important trend in the breast cancer diagnostics market. Several novel approaches have been developed that could be useful in detecting and treating breast cancer. For instance, breast tomosynthesis, or 3D mammography, captures photos of the breast from various angles and converts them into a 3-D model.

Mammography screening is the most substantial market in Asian Countries:

Based on methods, a mammogram is a leading method for breast cancer screening in Asian countries like India, Korea, Singapore, Thailand, China, Japan, and Malaysia. Japan, China, and Korea are the top three countries for breast cancer mammogram screening. Mammography is sophisticated medical imaging that utilizes a low-dose x-ray device to view human breasts indoors. Mammography plays a crucial role in Asia Pacific countries in treating women with breast disorders early.

Other modalities, such as ultrasound and (MRI) contrast-enhanced magnetic resonance imaging, play an essential role in breast cancer diagnostics, staging, and follow-up. Breast Magnetic Resonance Imaging (MRI) or breast ultrasound also helps detect breast cancer in women.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=asia-...